Scrip Asks...What Does 2024 Hold For Biopharma? Part 2: The Funding Environment, M&A And Partnering
Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director, Medical Management, Syneos Health; and Jian Wang, M.D., Executive Medical Director, Medical Management, Syneos Health regarding the range of treatment options for RA and the impact on therapy selection and challenges for patients.